Clinical trials recruiting for Advanced Lung Non-Small Cell Carcinoma
11
Recruiting trials
44
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Georgia | 5 |
| California | 4 |
| New York | 4 |
| Oregon | 4 |
| Washington | 4 |
| Arkansas | 3 |
| District of Columbia | 3 |
| Illinois | 3 |
| Indiana | 3 |
| Maryland | 3 |
| Michigan | 3 |
| Minnesota | 3 |
Top cities
Atlanta, Georgia 4Burlington, Wisconsin 3Burnsville, Minnesota 3Carterville, Illinois 3Coon Rapids, Minnesota 3Cudahy, Wisconsin 3Danville, Illinois 3Dayton, Ohio 3Decatur, Illinois 3Eau Claire, Wisconsin 3
Self-screener
Recruiting trials
- Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
- Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
- GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
- LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
- Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients
- Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- Understanding New Cachexia Subtypes Through Observational Epidemiological Research
Related conditions
Trials recruiting for Advanced Lung Non-Small Cell Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Stage IV Lung Cancer AJCC v8 45Metastatic Lung Non-Small Cell Carcinoma 20Stage III Lung Cancer AJCC v8 22Unresectable Lung Non-Small Cell Carcinoma 5Unresectable Colorectal Carcinoma 4Stage IV Pancreatic Cancer AJCC v8 19Stage IV Colorectal Cancer AJCC v8 21Recurrent Lung Non-Small Cell Carcinoma 12Pancreatic cancer 870
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Advanced Lung Non-Small Cell Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.